Search - tctmd.com

Displaying 321 - 340 of 353

Sort: Relevancy | Date

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Daily News

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Yael L. Maxwell

May 13, 2013

News Daily News

Automated System Using Field ECGs Speeds STEMI Diagnosis, Treatment

May 13, 2013

News Industry News

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

May 06, 2013

News Industry News

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

March 09, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

News Daily News

New Guidelines Take Integrated Approach to Stable Ischemic Heart Disease

Kim Dalton

November 19, 2012

News Conference News TCT 2012

Shift in Paradigm for HF Monitoring Needed

October 26, 2012

News Industry News

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

October 22, 2012

News Conference News TCT 2012

Globalization of Innovation a ‘Must Have’ to Improve Health Care Delivery

October 22, 2012

News Industry News

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

October 03, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Industry News

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

September 20, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

June 12, 2012

News Industry News

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

April 27, 2012

News Conference News ACC 2012

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

L.A. McKeown

March 25, 2012

News Daily News

Mixed IMPACT for Cardiac MRI: More Sensitive Than SPECT, But Less Specific

March 07, 2012

Advertisement

Tumor Marker Predicts TAVR Outcomes

Surgeons, Interventionalists Collaborate on Guidelines for Management of Aortic Stenosis

Automated System Using Field ECGs Speeds STEMI Diagnosis, Treatment

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System

TCTMD’s Top 10 Most Popular News Stories for 2012

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

New Guidelines Take Integrated Approach to Stable Ischemic Heart Disease

Shift in Paradigm for HF Monitoring Needed

Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients

Globalization of Innovation a ‘Must Have’ to Improve Health Care Delivery

Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Medtronic Announces First Patient Enrollment in Global Heart Rhythm Study

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

Renal Denervation Part 2: How Far, How Fast for Promising New Therapy?

Trial of Medtronic Symplicity™ Renal Denervation System Shows Significant Blood Pressure Reduction, With No Evidence of Renal Impairment, at Six Months Post Treatment

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

Mixed IMPACT for Cardiac MRI: More Sensitive Than SPECT, But Less Specific

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content